A recent study published in JAMA Neurology suggests that early treatment of obstructive sleep apnea (OSA) may lower the risk of developing Parkinson's disease. The research, led by Oregon Health & Science University (OHSU) in collaboration with the Veterans Affairs Portland Health Care System, analyzed health records from over 11 million veterans from the U.S. Department of Veterans Affairs between January 1999 and December 2022, with an average follow-up period of five years.
Read More
While the relative risk of developing Parkinson's was modest, findings revealed that veterans diagnosed with OSA within a two-year period were nearly twice as likely to receive a Parkinson's diagnosis up to six years later compared to those without sleep apnea. However, veterans who began using a continuous positive airway pressure (CPAP) machine within that same two-year window experienced a 30% reduction in their risk of being diagnosed with Parkinson's.
CPAP machines function by maintaining open airways, allowing individuals to receive adequate oxygen during sleep, thereby enhancing sleep quality and reducing related health risks. Researchers noted that the increased risk of Parkinson's remained significant even after accounting for other factors, such as high body mass index, diabetes, hypertension, depression, anxiety, and traumatic brain injuries.
Dr. Lee Neilson, a neurologist at the Portland VA Medical Center and co-author of the study, emphasized the relationship between sleep quality and brain health, stating that inadequate sleep and oxygen could contribute to the development of Parkinson's disease. He expressed satisfaction in finding that CPAP treatment makes a difference.
Parkinson’s disease, characterized by the degeneration of nerve cells, particularly in the substantia nigra, affects over 1.1 million people in the U.S., a figure projected to rise to 1.2 million by 2030, according to the Parkinson’s Foundation. Neilson highlighted the necessity of screening for sleep apnea, citing prior studies that underscore its detrimental health effects.
He cautioned that having sleep apnea does not mean one is destined to develop Parkinson’s, but it does present an increased risk. Neilson acknowledged limitations in the study, including a lack of representation from ethnic minorities and the inability to assess patients' adherence to CPAP therapy, which can be influenced by various factors such as PTSD or personal comfort.
Dr. Richard Isaacson, a preventative neurologist not involved in the study, noted that while sleep apnea may not directly cause Parkinson's, it could potentially accelerate its progression through oxygen deprivation and impact on vascular health. He called for further research to clarify the relationship between sleep apnea and Parkinson's risk factors.
Additionally, Dr. Stuart Isaacson, director of the Parkinson's Disease and Movement Disorders Center in Boca Raton, remarked on the need for caution in attributing causality based on the study's design. However, he acknowledged the significance of the findings, suggesting that treating sleep apnea may mitigate the risk of developing Parkinson's disease.